English

Proposal of Optomed’s Nomination Board

Report this content

Optomed Plc Stock Exchange Release 25 January 2022 at 8:00, Helsinki

Proposal of Optomed’s Nomination Board

Optomed’s Nomination Board proposes the following to the next Annual General Meeting:

 

Number of Board members

The Nomination Board proposes, that the number of members of the Board of Directors for the term expiring at the end of the Annual General Meeting 2023 is five.

 

Composition of the Board of Directors

The Nomination Board proposes to the Annual General Meeting that all the current Board members, Xisi Guo, Seppo Mäkinen, Petri Salonen, Reijo Tauriainen and Anna Tenstam are re-elected as Board members.


 

Proposal for the remuneration of the Board of Directors

The Nomination Board proposes to the Annual General Meeting that the annual remuneration payable to the members of the Board of Directors to be elected at the Annual General Meeting for the term until the end of the Annual General Meeting in 2023 to be as follows:

 

  • EUR 36,000 for the Chairman of the Board
  • EUR 18,000 for each Board member

 

In addition, the Nomination Board proposes that a meeting fee in the amount of EUR 300 is paid to the committee chairmen and EUR 200 to committee members for each committee meeting. The Shareholders’ Nomination Board proposes that 40 % of the Board remuneration is paid in Optomed shares and 60 % in cash. The remuneration will be paid once a year in August, after Optomed’s H1 report has been announced.

 

Nomination Board

Optomed’s Nomination Board consists of the following individuals:

  • Vesa Vanha-Honko, appointed by OP funds
  • Markus Lindqvist, appointed by Aktia funds
  • Keith Bonnici, appointed by Finnish Industry Investment Ltd

 

Petri Salonen (chairman of Optomed’s Board of Directors) serves as the Nomination Board's expert member and Vesa Vanha-Honko acts as the chairman of the Nomination Board.



Optomed Plc



Further enquiries

Vesa Vanha-Honko, Chairman of the Nomination Board, vesa@vesasco.fi

Sakari Knuutti, secretary of the Nomination Board, Optomed Plc, sakari.knuutti@optomed.com

 

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.

Subscribe